Anhui Bocheng Medical Investment Co., Ltd.

Overview

Anhui Bocheng Medical Investment Co., Ltd. is a Chinese company specializing in medical investment and healthcare services. Established in 2016, the company has developed a multi-level medical and service system, with its institutions primarily located in China and North America. It has also established extensive collaborations with renowned assisted reproductive institutions in Southeast Asia, Russia, Georgia, Mexico, and other countries. The company operates four direct-invested institutions, with its main institutions located in China and North America, and cooperative institutions spanning four continents. The company has a team of experienced American experts with over 30 years of experience and has provided reproductive services to over 30,000 families, achieving a fetal survival rate of 75% to 80%. The company has established high-end reproductive hospitals in Shanghai, offering comprehensive services such as reproductive health, obstetrics and gynecology, urology, MRI diagnostics, medical testing, and medical imaging. It has also established an international assisted reproductive exchange center, international medical department, and internet hospital. The company has set up high-end reproductive clinics in first-tier and new first-tier cities across China, inviting authoritative experts from public tertiary hospitals to provide convenient reproductive services, including fertility consultations, fertility checks, professional fertility adjustment advice, reproductive treatments, and gynecological treatments. The company has established offices in first- and second-tier provincial capital cities across China, serving industry channel institutions and the company's invested obstetrics and gynecology hospitals and overseas reproductive institutions. The company has established an integrated co-creation space in the Shanghai Hongqiao business district, attracting professionals from assisted reproduction, obstetrics and gynecology, genetic testing, and cross-border tourism services to provide more intimate medical services through technical exchanges and mutual cooperation. The company's future plans include deepening overseas布局 and establishing high-end clinics, assisted reproductive hospitals, and assisted reproductive channel offices in major cities in China, as well as establishing internet reproductive platforms and assisted reproductive incubation platforms to form an industrial chain闭环, providing intimate consultation services, professional medical guidance, and advanced assisted reproductive medical services for families troubled by infertility, and helping different types of families realize their dreams of successfully孕育后代.

Investment Focus

• Focus on assisted reproductive and obstetrics and gynecology institutions
• Presence in China and North America
• Collaboration with renowned assisted reproductive institutions in Southeast Asia, Russia, Georgia, Mexico, and other countries
• Experience in providing reproductive services to over 30,000 families
• Achieving a fetal survival rate of 75% to 80%
• Establishment of high-end reproductive hospitals and clinics in major cities
• Development of internet reproductive platforms and assisted reproductive incubation platforms
• Providing comprehensive services such as reproductive health, obstetrics and gynecology, urology, MRI diagnostics, medical testing, and medical imaging
• Offering services including fertility consultations, fertility checks, professional fertility adjustment advice, reproductive treatments, and gynecological treatments
• Establishment of integrated co-creation spaces to attract professionals from assisted reproduction, obstetrics and gynecology, genetic testing, and cross-border tourism services